$89.43
-0.26-0.29%
最終更新: Sep 3, 10:47 AM
Benzinga
Benzinga
Benzinga
木曜日, 9 03
DexCom Inc
DXCMNASDAQ
DexCom Earnings & Forecasts
DexCom (DXCM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
DexCom Guidance
DexCom (DXCM) は、7 30, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$5.18B - $5.25Bの範囲と予想しています。
以前のガイダンスと比較して、DexComは売上高予測を以前の範囲である維持から$5.16B - $5.25Bに引き上げました。
DexComは、29から10 27, 2022の間に7 30, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 7 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.61 | $0.47 | $0.65 | $0.57 |
| Actual | $0.70 | $0.56 | $0.68 | $0.61 |
| Surprise | +14.8% | +19.1% | +4.62% | +7.02% |
| Revenue | ||||
| Estimate | $1.29B | $1.18B | $1.25B | $1.18B |
| Actual | $1.31B | $1.19B | $1.26B | $1.21B |
| Surprise | +1.25% | +1.29% | +0.61% | +2.54% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.67 | $0.73 | $0.63 | $0.76 |
| Revenue | ||||
| Consensus | $1.33B | $1.40B | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved